A detailed history of Arrow Mark Colorado Holdings LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 1,354,508 shares of ORIC stock, worth $11.5 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,354,508
Previous 1,273,522 6.36%
Holding current value
$11.5 Million
Previous $9 Million 54.2%
% of portfolio
0.2%
Previous 0.12%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.52 - $11.9 $609,014 - $963,733
80,986 Added 6.36%
1,354,508 $13.9 Million
Q2 2024

Aug 14, 2024

SELL
$6.63 - $12.93 $1.57 Million - $3.07 Million
-237,339 Reduced 15.71%
1,273,522 $9 Million
Q1 2024

May 15, 2024

SELL
$8.04 - $16.03 $1.79 Million - $3.57 Million
-222,958 Reduced 12.86%
1,510,861 $20.8 Million
Q4 2023

Feb 14, 2024

BUY
$5.41 - $9.43 $1.71 Million - $2.98 Million
315,946 Added 22.28%
1,733,819 $16 Million
Q2 2023

Aug 14, 2023

BUY
$4.95 - $8.4 $5.75 Million - $9.76 Million
1,162,141 Added 454.44%
1,417,873 $11 Million
Q1 2023

May 15, 2023

SELL
$4.26 - $6.75 $1.14 Million - $1.81 Million
-267,426 Reduced 51.12%
255,732 $1.46 Million
Q4 2022

Feb 14, 2023

SELL
$2.41 - $5.89 $49,776 - $121,652
-20,654 Reduced 3.8%
523,158 $3.08 Million
Q3 2022

Nov 14, 2022

SELL
$3.15 - $5.24 $2.33 Million - $3.87 Million
-739,346 Reduced 57.62%
543,812 $1.74 Million
Q1 2022

May 16, 2022

SELL
$4.54 - $16.1 $2.8 Million - $9.92 Million
-616,233 Reduced 32.44%
1,283,158 $6.85 Million
Q4 2021

Feb 14, 2022

BUY
$12.01 - $20.3 $7.8 Million - $13.2 Million
649,684 Added 51.99%
1,899,391 $27.9 Million
Q3 2021

Nov 15, 2021

BUY
$15.9 - $25.22 $3.62 Million - $5.75 Million
227,809 Added 22.29%
1,249,707 $26.1 Million
Q2 2021

Aug 16, 2021

SELL
$17.37 - $25.34 $84,852 - $123,785
-4,885 Reduced 0.48%
1,021,898 $18.1 Million
Q1 2021

May 17, 2021

SELL
$23.67 - $36.85 $617,692 - $961,637
-26,096 Reduced 2.48%
1,026,783 $25.2 Million
Q4 2020

Feb 16, 2021

BUY
$20.32 - $39.8 $1.17 Million - $2.29 Million
57,497 Added 5.78%
1,052,879 $35.6 Million
Q3 2020

Nov 16, 2020

BUY
$19.5 - $31.26 $14.3 Million - $22.9 Million
733,604 Added 280.24%
995,382 $24.9 Million
Q2 2020

Aug 14, 2020

BUY
$25.68 - $38.12 $6.72 Million - $9.98 Million
261,778 New
261,778 $8.83 Million

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.